drugset / Trial / NCT04464577

A Study to Evaluate the Effect of Fluconazole, Bupropion, or Itraconazole on the Drug Levels and Safety of BMS-986235

NCT04464577

Phase 1 Withdrawn Bristol-Myers Squibb
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This study will evaluate the effect of inhibitors, at steady state, on the drug levels, safety, and tolerability of BMS-986235 when taken by healthy participants. The inhibitors to be utilized in this study are fluconazole, bupropion, and itraconazole.

Timeline

Start
2021-04-01
Primary completion
2021-06-07
Completion
2021-06-08

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS-986235 Small molecule
Subject Bupropion Small molecule
Subject Fluconazole Small molecule
Subject Itraconazole Small molecule

Indications

No indication recorded.